For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...
In 2022, when the surge in popularity of the GLP-1 class of weight loss and diabetes drugs really began, stories of surprise ...
A paper published Wednesday offers the strongest evidence yet that this is more than just anecdote, or a placebo effect: It ...
11h
The Healthy on MSNNearly 7,000 Bottles of a Heart and Diabetes Medication Recalled in At Least One StateHowever, a recent recall affecting 6,804 bottles of metformin means some of the 20 million Americans on metformin will want ...
Health and Me on MSN15h
GLP-1 Drugs Could Be Used To Treat Chronic Kidney DiseaseA latest research led by Dr Shuyao Zhang, an assistant professor of internal medicine at UT Southwestern in Dallas reveal the ...
2h
News Medical on MSNBlockbuster drug for diabetes and obesity could also help reduce alcohol intakeThe blockbuster drug semaglutide, better known as Ozempic for diabetes and Wegovy for obesity, could also help people cut down on their alcohol intake, according to new USC research.
People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With ...
The active ingredient in Ozempic and Wegovy was linked to reduced cravings for drinking alcohol among people with alcohol use ...
12h
HealthDay on MSNAge Differences Seen in Efficacy of Type 2 Diabetes TreatmentsSGLT2 inhibitors more cardioprotective in older versus younger people despite smaller reduction in HbA1c with older age ...
9h
News Medical on MSNDual-target drug may lead to new treatment approach for breast cancer patientsResearchers, led by the University of Melbourne's Professor Laura Mackay, a Laboratory Head and Immunology Theme Leader at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results